Summary
In this short article for an Australian nursing magazine, New Zealand mental health nurse Jason Watson challenges the idea that withholding gender-affirming treatment from young people drives them to suicide. He looks at six large, long-term studies from the Netherlands, Sweden, Denmark, the UK and Finland. In his reading, suicide rates among transgender people stayed well above the general population after treatment, rates fell over time only for trans women in one Dutch study, and the Tavistock clinic review found no rise in youth suicides after access to puberty blockers was restricted in England. He concludes that the 'transition or suicide' claim is weak at best. The article was printed in July 2026, then removed from the journal's website after complaints; the nurses' union apologised for publishing it but later said this did not imply misconduct by the author. It is an opinion piece, not a systematic review: it picks a handful of studies, most of them about adults, and some of its readings go further than the studies' own authors. For example, the Finnish study it relies on most concluded that suicide risk was explained by mental illness and that gender reassignment did not change suicide risk either way.
Key findings
- Watson sætter spørgsmålstegn ved den ofte gentagne påstand om, at unge, der nægtes kønsbekræftende behandling, har højere risiko for selvmord – en påstand fremsat af WPATH og amerikanske sundhedsmyndigheder.
- Han gennemgår seks langtidsopfølgningsstudier fra Holland, Sverige, Danmark, Storbritannien og Finland med fra 324 til over 15.000 personer og med opfølgning fra 5 til 46 år.
- Han oplyser, at selvmords- og dødsraterne blandt transkønnede forblev højere end i den almindelige befolkning efter behandling, og at kun ét hollandsk studie fandt, at selvmord faldt over tid, og det gjaldt transkvinder.
- Han fremhæver gennemgangen af selvmord ved Tavistock-klinikken i England, som fandt 12 selvmord og ingen stigning i selvmord blandt unge, efter at pubertetsblokkere blev begrænset, trods forudsigelser om en kraftig stigning.
- Han konkluderer, at fortællingen om 'overgang eller selvmord' er 'i bedste fald svag og i værste fald simpelthen forkert', i tråd med Cass-rapportens konklusion om, at det meste af forskningen på området er af dårlig kvalitet.
- Den australske sygeplejerskefagforening fjernede artiklen fra tidsskriftets hjemmeside i juli 2026 og undskyldte, at den var blevet udgivet, og præciserede senere, at der ikke var tale om en konstatering af forseelse fra forfatterens side.
Abstract
This short article examines the narrative that trans youth who are not provided with gender-affirming healthcare face an increased risk of suicide, a view stated by WPATH's Standards of Care 8 and the US Assistant Secretary for Health in 2022. Noting the Cass Review's finding that research in this field is of poor quality, the author summarises six long-term follow-up studies from the Netherlands (Wiepjes 2020; de Blok 2021), Sweden (Dhejne 2011), Denmark (Erlangsen 2023), England (Appleby 2024, a review of suicides among Tavistock gender clinic patients) and Finland (Ruuska 2024), with sample sizes from 324 to 15,032 and follow-up from five to 46 years, and describes what each reported about suicide and mortality.
Conclusion
Only one finding, the decline in suicide among trans women over time in Wiepjes (2020), appeared to support the narrative that lack of access to gender-affirming care increases suicide risk. The author argues the other studies showed no evidence that treatment reduced suicidal behaviour, and reported higher 'other' mortality after treatment, and that Ruuska (2024), the only study with a matched control group, found much higher suicide and overall mortality among trans people. He concludes the 'trans suicide narrative' is 'at least tenuous and at most simply incorrect', consistent with the Cass Review's view that most research in this field is of poor quality.